Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets
Locations
1
China
Henan Cancer Hospital
Zhengzhou, Henan, China
Start Date
April 1, 2025
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
March 27, 2025
NCT05067257
NCT04572776
NCT01333540
NCT01901328
NCT01965158
NCT01100151
Lead Sponsor
Henan Cancer Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions